Evidence map›Paper›PMID 34075334›Full record

ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2022

Smell and Taste Disturbance in COVID-19 Patients: A Prospective Multicenteric Review.

Subash Bhatta, Dibya Sharma, Santosh Sharma, Leison Maharjan, Sushma Bhattachan, Mukesh Kumar Shah, Aditya Singhal, Asheesh Dora Ghanpur, Dushyanth Ganesuni, Shraddha Jayant Saindani

Open access · bronzeAbstract read
In one paragraph

Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Olfactory Bulb and Amygdala Gene Expression Changes in Subjects Dying with COVID-19.medRxiv : the preprint server for health sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Subash BhattaIndira Gandhi Memorial Hospital, Male', Maldives.ORCID 0000-0002-9393-5774
Dibya SharmaIndira Gandhi Memorial Hospital, Male', Maldives.
Santosh SharmaDevdaha Medical College, Butwal, Nepal.
Leison MaharjanPatan Academy of Health Sciences, Patan, Nepal.
Sushma BhattachanHospital for Advanced Medicine and Surgery, Kathmandu, Nepal.
Mukesh Kumar ShahNational Medical College, Birgunj, Nepal.
Aditya SinghalRajshree Medical Research Institute, Bareily, India.
Asheesh Dora GhanpurOsmania Medical College, Hyderabad, India.
Dushyanth GanesuniContinental Hospital and Research Center, Hyderabad, India.
Shraddha Jayant SaindaniDeenanath Mangeshkar Hospital and Research Center, Pune, India.
Indira Gandhi Memorial Hospital · MVNepal Medical College Teaching Hospital · NPCivil Service Hospital · NPDeenanath Mangeshkar Hospital and Research Center · INOsmania Medical College · INPatan Academy of Health Sciences · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To study the incidence of the smell and taste disturbance in the COVID-19 patients and a follow up at 4 months to observe for the duration of resolution of these symptoms. This is a multicentric prospective study carried out in 3 different countries, from April, 2020 to January, 2021. The COVID-19 positive patients, aged between 15 and 60 years, were inquired about the presence of any smell or taste related symptoms. The same patients were followed up with the telephonic interview after 2 months and then after 4 months, respectively. The duration of resolution of the smell and taste disturbance symptoms was noted. Total of 188 COVID-19 positive patients, average age 33.1 ± 1.7 years, 54.2% males and 45.8% female were included in the study. The smell disturbance was present in 60.6% (hyposmia 36.1%, anosmia 20.2%, and parosmia 4.2%) and taste disturbance in 28.7% of patients (hypogeusia 20.2%, ageusia 6.9%, and parageusia 1.6%). There was improvement of anosmia by 97.4, hyposmia by 95.6%, parosmia by 100%, ageusia by 100%, hypogeusia 94.8%, and parageusia by 66.7%, at 4 months follow up. The present study concludes that the smell and taste disturbances are one of the main early presenting features of the COVID-19 infection. The temporary effect of the COVID-19 infection on the olfactory and gustatory pathway was also highlighted with more than 95% patients improving at 4 months of follow up.

Indexed as

COVID-19 infectionProspectiveSmell disturbanceTaste disturbance

Identifiers

PMID34075334
PMCPMC8159719
OpenAlexW3165185819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.